COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

In line with SARS and MERS, the SARS-CoV-2/COVID-19 pandemic is one of the largest challenges in medicine and health care worldwide. SARS-CoV-2 infection/COVID-19 provides numerous therapeutic targets, each of them promising, but not leading to the success of therapy to date. Neither an antiviral no...

Full description

Bibliographic Details
Main Authors: Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
SARS-CoV-2
COVID-19
lysosomotropic compounds
lysosome
cytokine storm
cytokine release syndrome
Online Access:https://www.mdpi.com/1422-0067/21/14/4953

Internet

https://www.mdpi.com/1422-0067/21/14/4953

Similar Items